查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363121

結核病診斷市場規模、佔有率、趨勢分析報告：按測試類型、最終用途、地區、細分趨勢，2023-2030 年

Tuberculosis Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Radiographic Method, Diagnostic Laboratory Methods, Nucleic Acid Testing, Phage Assay), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

結核病診斷市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球結核病診斷市場規模預計將達到33.4億美元，2023年至2030年年複合成長率為5.2%。

干擾素γ釋放測定（IGRA）、血清學技術和核酸檢測等先進診斷技術的出現導致了診斷劑的高利用率。此外，抗原檢測等照護端 (POC) 技術也提高了結核病診斷率。

這些先進的方法，包括 POC 診斷，價格實惠、準確、方便，並且可以快速提供結果。此外，結核病負擔的增加是推動市場成長的主要要素。根據世界衛生組織（WHO）估計，2014年全球結核病患者人數約960萬人。這種高患病促使政府、醫療機構、研究機構和市場相關人員採取措施遏制這種感染疾病的爆發。

發展重點是提高高負擔地區的篩檢率、負擔得起的診斷、先進的調查方法、快速的臨床決策和降低死亡率。提高預防性和治療性診斷率是這些配合措施的最終結果。因此，診斷測試的需求迅速增加，結核病診斷市場不斷擴大。

結核病診斷市場報告亮點

  • 根據檢驗類型，結核病診斷市場分為X光檢測、實驗室診斷、核酸檢測、噬菌體檢測、潛伏感染檢測、細胞激素檢測及抗藥性檢測。
  • 由於其成本效益和易於執行，診斷實驗室測試在測試類型領域佔據主導地位，2015 年市場佔有率為 38.0%。診斷實驗室測試包括塗片顯微鏡檢查和基於培養的測試。高負擔地區缺乏採用先進技術並依賴這些方法的財政和技術能力，從而促進了診斷實驗室檢測領域的成長。
  • 然而，準確度低和處理時間長是此診斷方法的限制要素。因此，醫療保健組織努力在發展中地區實施先進技術。
  • 因此，核酸檢測領域和潛在感染疾病檢測領域，包括皮膚檢測和IGRA，可能呈現盈利成長率。這些方法透過克服上述限制來提高診斷的負擔能力、處理時間和準確性。
  • 結核病的抗藥性是醫療專業人員關注的主要問題之一，因為錯誤的用藥方案或錯誤的劑型導致的不當治療會導致結核病患者在治療過程中產生抗藥性。因此，抗藥性檢測領域也預計將呈現良好的成長動能。
  • 亞太地區人口眾多，結核病罹患率率高，在2015年主導了全球結核病診斷市場。世界衛生組織表示，印度、中國、阿富汗和印尼等國家是控制這場疫情的優先地區。
  • 結核病檢測市場的參與者包括 Thermo Fisher Scientific, Inc.、Hologic Corporation、Abbott Laboratories、Alere, Inc.、Becton、Dickinson and Company、F. Hoffmann-La Roche AG、bioMerieux SA、Sanofi、Cepheid、Hain Lifescience GmbH、包括凱傑。
  • 新產品發布、合作、併購和區域擴張是這些產業參與者採取的關鍵策略措施。
  • 例如，2016年7月，生物梅里埃推出了用於結核病鑒定的新型CE標誌資料庫和試劑組VITEK MS。該新產品的推出預計將有助於該公司擴大市場佔有率。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 結核病診斷市場變數、趨勢、範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 普及和成長預測圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 結核病診斷市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 結核病診斷：檢測類型的估計和趨勢分析

  • 結核病診斷市場：要點
  • 結核病診斷市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 射線照相
  • 診斷測試方法
  • 核酸檢測
  • 噬菌體測定
  • 檢測潛伏感染（皮膚試驗和IGRA）
  • 細胞激素檢測分析
  • 抗藥性檢測（DST）
  • 其他

第5章 結核病診斷：按最終用途的估計和趨勢分析

  • 結核病診斷市場：要點
  • 結核病診斷市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 診斷實驗室
  • 醫院和診所
  • 其他

第6章 結核病診斷市場：區域估計與趨勢分析

  • 區域展望
  • 按地區分列的結核診斷市場：要點
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • F. Hoffmann-La Roche AG
    • Thermo Fisher Scientific Inc.
    • BioMerieux SA
    • Hain Lifescience GmbH
    • QIAGEN GmbH
    • Cepheid
    • Hologic, Inc.
    • BD
Product Code: GVR-1-68038-098-9

Tuberculosis Diagnostics Market Growth & Trends:

The global tuberculosis diagnostics market size is expected to reach USD 3.34 billion by 2030, registering a CAGR of 5.2% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Advent of advanced diagnostic methods such as Interferon-gamma Release Assay (IGRA), serological methods, and nucleic acid testing have resulted in the high usage rate of diagnostics. Moreover, Point of Care (POC) technologies such as antigen assays are also promoting the diagnosis rate of TB.

These advanced methods including POC diagnostics are affordable, accurate, simple, and yield quick results. Furthermore, the rising burden of TB is the primary factor responsible for the lucrative market growth. As per the World Health Organization, the global estimates of patients afflicted with TB were around 9.6 million in 2014. This high prevalence rate has led the government, healthcare organizations, research institutes, and market players to initiate endeavors directed toward containing the incidence of this infectious disease.

The increasing screening rate in the high burden regions, affordability of diagnostics, advanced methodologies, faster clinical decisions, and reduction in mortality rate are the focal areas of development. Improved preventive and curative diagnosis rates are the end results of these initiatives. This has led to a subsequent upsurge in the demand for diagnostic tests and the TB diagnostics market.

Tuberculosis Diagnostics Market Report Highlights:

  • Based on tests type, the tuberculosis diagnostics market is segmented into radiographic methods, diagnostic laboratory methods, nucleic acid testing, phage assay, detection of latent infection, cytokine detection assay, and detection of drug resistance.
  • Diagnostic laboratory tests dominated the test type segment with 38.0% market share in 2015 as they are cost efficient and easy-to-perform. Diagnostic laboratory tests include smear microscopy and culture-based tests. The high burden regions rely on these methodologies due to their financial and technical incapability to incorporate advanced technologies thus contributing to the growth of the diagnostic laboratory tests segment.
  • However, compromised accuracy and the longer processing time are the limiting factor for the diagnostics. Hence, healthcare agencies are striving to implement advanced techniques in the developing regions.
  • As a result, nucleic acid tests segment and the latent infection detection segment, which includes skin tests and IGRA, are likely to exhibit a profitable growth rate. These methods overcome the aforementioned limitations thus improving affordability, processing time and accuracy of the diagnostic method.
  • Drug resistance in tuberculosis is one of the primary concerns for healthcare professionals as improper treatment due to wrong drug regimen and incorrect dosage forms lead to the development of drug resistance in TB patients undergoing treatment. Hence, the drug resistance detection segment is also anticipated to witness lucrative growth.
  • Asia Pacific owing to its huge population base and high burden of TB dominated the global TB diagnostics market in 2015. As per the WHO, countries such as India, China, Afghanistan, and Indonesia are priority regions for control of this communicable disease.
  • The players in the TB testing market include Thermo Fisher Scientific, Inc., Hologic Corporation, Abbott Laboratories, Alere, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche AG, bioMerieux SA, Sanofi, Cepheid, Hain Lifescience GmbH, and QIAGEN.
  • New product launches, collaboration, mergers & acquisitions, and regional expansion are the key strategic initiatives undertaken by these industry players
  • For instance, in July 2016, bioMerieux launched a novel CE marked database and reagents kit VITEK MS for the identification of TB. This new product launch is anticipated to help the company increase its market share.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Test Type
    • 1.1.2. End-use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Test type outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Tuberculosis Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Tuberculosis Diagnostics Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Tuberculosis Diagnostics: Test Type Estimates & Trend Analysis

  • 4.1. Tuberculosis Diagnostics Market: Key Takeaways
  • 4.2. Tuberculosis Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Radiographic Method
    • 4.3.1. Radiographic method market estimates and forecasts, 2018 to 2030, (USD Million)
  • 4.4. Diagnostic Laboratory Methods
    • 4.4.1. Diagnostic laboratory methods market estimates and forecasts, 2018 to 2030, (USD Million)
  • 4.5. Nucleic Acid Testing
    • 4.5.1. Nucleic acid testing market estimates and forecasts, 2018 to 2030, (USD Million)
  • 4.6. Phage Assay
    • 4.6.1. Phage assay market estimates and forecasts, 2018 to 2030, (USD Million)
  • 4.7. Detection of Latent Infection (Skin Test & IGRA)
    • 4.7.1. Detection of latent infection market estimates and forecasts, 2018 to 2030, (USD Million)
  • 4.8. Cytokine Detection Assay
    • 4.8.1. Cytokine detection assay market estimates and forecasts, 2018 to 2030, (USD Million)
  • 4.9. Detection of Drug Resistance (DST)
    • 4.9.1. Detection of drug resistance (DST) market estimates and forecasts, 2018 to 2030, (USD Million)
  • 4.10. Other Methods
    • 4.10.1. Other methods market estimates and forecasts, 2018 to 2030, (USD Million)

Chapter 5. Tuberculosis Diagnostics: End-use Estimates & Trend Analysis

  • 5.1. Tuberculosis Diagnostics Market: Key Takeaways
  • 5.2. Tuberculosis Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Diagnostic Laboratories
    • 5.3.1. Diagnostic laboratories market estimates and forecasts, 2018 to 2030, (USD Million)
  • 5.4. Hospitals & Clinics
    • 5.4.1. Hospitals & clinics market estimates and forecasts, 2018 to 2030, (USD Million)
  • 5.5. Others
    • 5.5.1. Others market estimates and forecasts, 2018 to 2030, (USD Million)

Chapter 6. Tuberculosis Diagnostics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Tuberculosis Diagnostics Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Abbott Laboratories
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Becton, Dickinson and Company
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. F. Hoffmann-La Roche AG
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Thermo Fisher Scientific Inc.
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. BioMerieux SA
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Hain Lifescience GmbH
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. QIAGEN GmbH
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Cepheid
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Hologic, Inc.
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. BD
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 3 North America tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 4 North America tuberculosis diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 6 U.S. tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Canada tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 8 Canada tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Europe tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 10 Europe tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Europe tuberculosis diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 13 Germany tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 UK tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 15 UK tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 France tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 17 France tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Italy tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 19 Italy tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Spain tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 21 Spain tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Sweden tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 23 Sweden tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Norway tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 25 Norway tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Denmark tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 27 Denmark tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific tuberculosis diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 31 China tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 32 China tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Japan tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 34 Japan tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 India tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 36 India tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Australia tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 38 Australia tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 Thailand tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 40 Thailand tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 South Korea tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 42 South Korea tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Latin America tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 44 Latin America tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Latin America tuberculosis diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 47 Brazil tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Mexico tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 49 Mexico tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Argentina tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 51 Argentina tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa tuberculosis diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 56 South Africa tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 UAE tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 60 UAE tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 62 Kuwait tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million) 

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Tuberculosis diagnostics: Market outlook
  • Fig. 9 Tuberculosis diagnostics: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Tuberculosis diagnostics market driver impact
  • Fig. 15 Tuberculosis diagnostics market restraint impact
  • Fig. 16 Tuberculosis diagnostics market strategic initiatives analysis
  • Fig. 17 Tuberculosis diagnostics market: Test type movement analysis
  • Fig. 18 Tuberculosis diagnostics market: Test type outlook and key takeaways
  • Fig. 19 Radiographic method market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Diagnostic laboratory methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Nucleic acid testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Phage assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Detection of latent infection (skin test & IGRA) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Cytokine detection assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Detection of drug resistance (DST) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Other methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Tuberculosis diagnostics market: End-use movement analysis
  • Fig. 28 Tuberculosis diagnostics market: End-use outlook and key takeaways
  • Fig. 29 Diagnostic laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Hospitals & clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Global tuberculosis diagnostics market: Regional movement analysis
  • Fig. 33 Global tuberculosis diagnostics market: Regional outlook and key takeaways
  • Fig. 34 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)